Platelets for Acute Wound Healing
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00125086|
Recruitment Status : Completed
First Posted : July 29, 2005
Last Update Posted : September 14, 2005
|Condition or disease||Intervention/treatment||Phase|
|Wounds||Device: autologous platelet gel||Not Applicable|
Platelets contribute to the healing process in soft tissue by providing the initial hemostasis that occurs following injury, a framework for fibrin matrix formation and contribution of growth factors.
According to the US National Institutes of Health, surgical procedures are considered a form of controlled injury, so many of the complications faced by surgery patients are very similar to those faced by trauma patients. Scientists are currently investigating ways to treat wounds caused by trauma, burns or surgical inventions with biological agents (i.e. growth factors) or new drugs. Growth factor priming of acute wound sites pre-activates the cellular and molecular components of tissue repair, prior to tissue injury.
Objectives are aimed at gathering information to establish evidence that autologous platelet gel positively effects the healing of acute wounds.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||4 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Platelets in Acute Wounds: A Punch Biopsy Study (PAWS II)|
|Study Start Date :||July 2005|
|Study Completion Date :||February 2006|
- Time to 100% wound closure, measured at Days 7, 14, 21, 28, 35
- Measurements of wound depth at each visit
- Measurement of residual scarring at 6 months post wounding
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00125086
|United States, Minnesota|
|DaVita Clinical Research|
|Minneapolis, Minnesota, United States, 55404|
|Principal Investigator:||David Hom, M.D.||University of Minnesota - Clinical and Translational Science Institute|